Professor | Dongcheng Wu | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Dongcheng Wu
Contact Information	bcduwu@hotmail.com
Language ability	Chinese, English
Province	Hubei

Upload Avatar (500 x 500)

Name

Dongcheng Wu

Contact Information

bcduwu@hotmail.com

Language ability

Chinese, English

Province

Hubei

University/Lab Affiliation and Title	Wuhan University
Faculty	Basic Medical Sciences
Academic Background & Achievements	2002-2005: PhD in Clinical Laboratory Science, Wuhan University 1998-2000: Master's in Biochemistry, Hong Kong University of Science and Technology 1990-1993: Master's in Biochemistry, Hubei Medical University 1982-1987: Bachelor's in Clinical Medicine, Hubei Medical College
Work Experience	2009-present: Professor, Basic Medical College, Wuhan University 2012-present: Chairman, General Manager, Chief Scientist, Wuhan Hamilton Biotechnology Co., Ltd. 2014-2015: Dean, College of Chemistry and Life Sciences, Hubei Second Normal University 2007-2009: Research Scientist, McMaster University, Canada 2005-2007: Postdoctoral Fellow, McMaster University, Canada 2001-2005: Visiting Scholar, McMaster University, Canada 1993-1998: Lecturer, Basic Medical College, Hubei Medical University
Awards	2020: Selected for the 10th batch of Hubei Province Hundred Talents Plan 2020: Leader of the Entrepreneurial Leading Team Project of Zengcheng District, Guangzhou 2016: Innovation and Entrepreneurship Mentor, Basic Medical College, Wuhan University 2012: Selected for the 5th batch of '3551 Optical Valley Talent Plan', Wuhan 2009: Hubei Province Chutian Scholar Distinguished Professor 2008: Postdoctoral Outstanding Research Award, Canadian Society of Nephrology 2003: Third Prize, Hubei Province Natural Science Award

University/Lab Affiliation and Title

Wuhan University

Faculty

Basic Medical Sciences

Academic Background & Achievements

2002-2005: PhD in Clinical Laboratory Science, Wuhan University
1998-2000: Master's in Biochemistry, Hong Kong University of Science and Technology
1990-1993: Master's in Biochemistry, Hubei Medical University
1982-1987: Bachelor's in Clinical Medicine, Hubei Medical College

Work Experience

2009-present: Professor, Basic Medical College, Wuhan University
2012-present: Chairman, General Manager, Chief Scientist, Wuhan Hamilton Biotechnology Co., Ltd.
2014-2015: Dean, College of Chemistry and Life Sciences, Hubei Second Normal University
2007-2009: Research Scientist, McMaster University, Canada
2005-2007: Postdoctoral Fellow, McMaster University, Canada
2001-2005: Visiting Scholar, McMaster University, Canada
1993-1998: Lecturer, Basic Medical College, Hubei Medical University

Awards

2020: Selected for the 10th batch of Hubei Province Hundred Talents Plan
2020: Leader of the Entrepreneurial Leading Team Project of Zengcheng District, Guangzhou
2016: Innovation and Entrepreneurship Mentor, Basic Medical College, Wuhan University
2012: Selected for the 5th batch of '3551 Optical Valley Talent Plan', Wuhan
2009: Hubei Province Chutian Scholar Distinguished Professor
2008: Postdoctoral Outstanding Research Award, Canadian Society of Nephrology
2003: Third Prize, Hubei Province Natural Science Award

Areas of Focus	Pathological molecular mechanisms of diabetic nephropathy Development of new drugs from stem cells focusing on treatment of diabetic nephropathy, knee osteoarthritis, premature ovarian failure, and acute lung injury
Publications	Intra-articular injection of human umbilical cord mesenchymal stem cells ameliorates monosodium iodoacetate-induced osteoarthritis in rats by inhibiting cartilage degradation and inflammation, Zhang Q, Xiang E, Rao W, Zhang YQ, Xiao CH, Li CY, Han B, Wu DC, 2021 Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis, Xiang E, Han B, Zhang Q, Rao W, Wang ZF, Chang C, Zhang YQ, Tu CS, Li CY, Wu DC, 2020 Umbilical Cord-Derived Mesenchymal Stem Cells Ameliorate Nephrocyte Injury and Proteinuria in a Diabetic Nephropathy Rat Model, Chen L, Xiang E, Li CY, Han B, Zhang Q, Rao W, Xiao CH, Wu DC, 2020 Intrauterine transplantation of autologous menstrual blood stem cells increases endometrial thickness and pregnancy potential in patients with refractory intrauterine adhesion, Ma HN, Liu MT, Li YF, Wang W, Yang KQ, Lu LY, He M, Deng TR , Li ML, Wu DC, 2020 ABIN1 inhibits HDAC1 ubiquitination and protects it from both proteasome- and lysozyme-dependent degradation, Ma Y, Yuan S, Tian X, Lin S, Wei S, Hu T, Chen S, Li X, Chen S, Wu DC, Wang M, Guo D, 2018 Retinoids Regulate Adipogenesis Involving the TGFβ/SMAD and Wnt/β-Catenin Pathways in Human Bone Marrow Mesenchymal Stem Cells, Cao J, Ma Y, Yao W, Zhang X, Wu DC, 2017 Alterations in expression levels of genes in p53-related pathways determined using RNA-Seq analysis in patients with breast cancer following CIK therapy, Hu Z, Zhang X, Yang H, Qin S, Liu Y, Xiong W, Yuan B, Li L, Yao W, Wu DC, 2017

Areas of Focus

Pathological molecular mechanisms of diabetic nephropathy
Development of new drugs from stem cells focusing on treatment of diabetic nephropathy, knee osteoarthritis, premature ovarian failure, and acute lung injury

Publications

Intra-articular injection of human umbilical cord mesenchymal stem cells ameliorates monosodium iodoacetate-induced osteoarthritis in rats by inhibiting cartilage degradation and inflammation, Zhang Q, Xiang E, Rao W, Zhang YQ, Xiao CH, Li CY, Han B, Wu DC*, 2021
Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis, Xiang E, Han B, Zhang Q, Rao W, Wang ZF, Chang C, Zhang YQ, Tu CS, Li CY, Wu DC*, 2020
Umbilical Cord-Derived Mesenchymal Stem Cells Ameliorate Nephrocyte Injury and Proteinuria in a Diabetic Nephropathy Rat Model, Chen L, Xiang E, Li CY*, Han B, Zhang Q, Rao W, Xiao CH, Wu DC*, 2020
Intrauterine transplantation of autologous menstrual blood stem cells increases endometrial thickness and pregnancy potential in patients with refractory intrauterine adhesion, Ma HN, Liu MT, Li YF, Wang W, Yang KQ, Lu LY, He M, Deng TR , Li ML, Wu DC*, 2020
ABIN1 inhibits HDAC1 ubiquitination and protects it from both proteasome- and lysozyme-dependent degradation, Ma Y, Yuan S, Tian X, Lin S, Wei S, Hu T, Chen S, Li X, Chen S, Wu DC*, Wang M, Guo D, 2018
Retinoids Regulate Adipogenesis Involving the TGFβ/SMAD and Wnt/β-Catenin Pathways in Human Bone Marrow Mesenchymal Stem Cells, Cao J, Ma Y, Yao W, Zhang X, Wu DC*, 2017
Alterations in expression levels of genes in p53-related pathways determined using RNA-Seq analysis in patients with breast cancer following CIK therapy, Hu Z, Zhang X, Yang H, Qin S, Liu Y, Xiong W, Yuan B, Li L, Yao W, Wu DC*, 2017

Diabetic Nephropathy Molecular Mechanisms Stem Cells Drug Development Knee Osteoarthritis Premature Ovarian Failure Acute Lung Injury Clinical Research Umbilical Cord Mesenchymal Stem Cells Therapeutics

Sifeng Chen - Fudan University

Yongsheng Tu - Guangzhou Medical University

Yuxiang Wang - Fudan University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us